| Q4 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-03-29 | ||||||
| REV | |||||||
| Q3 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 12.030 | 14.560 | 2.5300 | ||||
| REV | 5.930B | 7.178B | 1.248B |
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of BioNTech (NASDAQ: BNTX) through any online brokerage.
Other companies in BioNTech’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Amgen (NASDAQ:AMGN), Mirati Therapeutics (NASDAQ:MRTX) and United Therapeutics (NASDAQ:UTHR).
The latest price target for BioNTech (NASDAQ: BNTX) was reported by Morgan Stanley on January 18, 2022. The analyst firm set a price target for 284.00 expecting BNTX to rise to within 12 months (a possible 75.07% upside). 20 analyst firms have reported ratings in the last year.
The stock price for BioNTech (NASDAQ: BNTX) is $162.22 last updated Fri Jan 28 2022 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for BioNTech.
BioNTech’s $Q4 earnings are confirmed for after-market on March 29, 2022.
There is no upcoming split for BioNTech.
BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.